Literature DB >> 3920317

Suppression of cytotoxic T lymphocyte activation by L-ornithine.

W Dröge, D Männel, W Falk, V Lehmann, H Schmidt, S Nick, B Häcker-Shahin, R Jänicke.   

Abstract

The effect of L-ornithine on several types of immune reactions was analyzed. L-ornithine was found to suppress the activation of cytotoxic T lymphocytes (CTL) in vivo and in vitro. This suppressive effect was not observed with the structural analogues D-ornithine, L-lysine, or putrescine or with the amino acids L-histidine or L-alanine. The concentration of 9 X 10(-3) M L-ornithine was found to mediate a practically complete suppression of the cytotoxic response in vitro if applied on day 0 or day 1 of the culture, but a comparably weak suppression if applied on day 3. The same concentration of L-ornithine had no effect on the production of the lymphokines interleukin 2 (IL 2) and gamma-interferon (IFN-gamma). This concentration of ornithine had also no substantial effect on several types of proliferative responses, including the allogeneic mixed lymphocyte reaction, the concanavalin A-activated IL 2-dependent proliferation of thymocytes, and IL 2-dependent proliferation of the T cell clone W-2. These observations suggest that L-ornithine inhibits selectively the differentiation of CTL effector cells. By the criteria tested, the immunosuppressive effect of L-ornithine is more selective than that of cyclosporine A, which was previously found to suppress not only the activation of cytotoxic activity but also proliferative responses and the production of the lymphokines IL 2 and IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920317

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

Review 1.  Metabolic communication in the tumour-immune microenvironment.

Authors:  Kung-Chi Kao; Stefania Vilbois; Chin-Hsien Tsai; Ping-Chih Ho
Journal:  Nat Cell Biol       Date:  2022-10-13       Impact factor: 28.213

Review 2.  Myeloid Cell-Derived Arginase in Cancer Immune Response.

Authors:  Tomasz M Grzywa; Anna Sosnowska; Paweł Matryba; Zuzanna Rydzynska; Marcin Jasinski; Dominika Nowis; Jakub Golab
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

3.  Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events.

Authors:  Siew C Ng; Ye Peng; Lin Zhang; Chris Kp Mok; Shilin Zhao; Amy Li; Jessica Yl Ching; Yingzhi Liu; Shuai Yan; Dream L S Chan; Jie Zhu; Chunke Chen; Adrian Ch Fung; Kenneth Ky Wong; David Sc Hui; Francis Kl Chan; Hein M Tun
Journal:  Gut       Date:  2022-02-09       Impact factor: 31.793

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.